PASTEUR Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
The PASTEUR Act of 2026 amends the Public Health Service Act to establish a federal contract program that provides annual payments to pharmaceutical companies developing new antimicrobial drugs targeting resistant pathogens identified by the CDC or the Secretary of Health and Human Services. Eligible drugs must address unmet medical needs and are scored based on clinical benefits, innovative characteristics, and public health value. In exchange for payments, drug sponsors must ensure commercial availability, supply for testing, implement stewardship education, track resistance data, and maintain reliable supply chains.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.